Literature DB >> 25537895

[Effect of miR-92b on migration, adhesion and invasion of human gastric cancer cell line SGC7901].

Weihua Wang1, Changzheng Wang, Yi Jiang, Benyan Wu.   

Abstract

OBJECTIVE: To investigate the effect of miR-92b on the migration, adhesion and invasion of gastric cancer cell line SGC7901.
METHODS: The miR-92b inhibitor and mimics were transiently transfected in SGC7901 cells. The changes in the migration, adhesion and invasion of the transfected cells were tested with wound healing assay, Transwell migration assay, matrigel adhesion and Transwell invasion assay. The cellular expression of E-cadherin, vimentin, Akt and p-Akt were analyzed by Western blotting.
RESULTS: The migration, adhesion and invasion assays showed that transfection with the inhibitor of miR-92b obviously decreased the numbers of gastric cancer cells. The expression of E-cadherin, AKT, and pAKT increased and vimentin decreased significantly in the cells transfected with the inhibitor of miR-92b. Transfection with the mimics of miR-92b produced opposite effects in SGC7901 cells.
CONCLUSION: miR-92b promotes the migration, adhesion and invasion of human gastric cancer cell line SGC7901 by mediating epithelial-mesenchymal transition, and may accelerate tumor cell metastasis via signaling pathways other than PI3K/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25537895

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  2 in total

1.  uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis.

Authors:  Yan Liu; Yun Feng Pan; You-Qiu Xue; Lin-Kai Fang; Xing-Hua Guo; Xin Guo; Meng Liu; Bi-Yao Mo; Meng-Ru Yang; Fang Liu; Yun-Ting Wu; Nancy Olsen; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2017-01-16       Impact factor: 11.530

2.  miRNA Sequence Analysis in Patients With Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Seref Bugra Tuncer; Betul Celik; Demet Akdeniz Odemis; Seda Kılıc Erciyas; Ozge Sukruoglu Erdogan; Mukaddes Avsar; Gozde Kuru Turkcan; Hulya Yazici
Journal:  Pathol Oncol Res       Date:  2022-01-24       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.